Trading Signals: BAX Stock Price Prediction and Forecast (Mon. Dec. 1, 2014 - Wed. Sep. 27, 2023)(Baxter International Inc.)
| BAX latest price $70.1400 (0.78%) ($69.7000 - $70.4500) on Wed. Jan. 24, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 0.98% (three month average) | RSI | 64 | Latest Price | $70.1400(0.78%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BAX advances 0.6% a day on average for past five trading days. | Weekly Trend | BAX advances 0.8% a week on average for past two weeks. | Market Behavior | Rotation from growth to value for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support BAX advance at 0% a week (0% probability) XLV(58%) SPLV(53%) VYM(52%) XLP(51%) IVE(50%) | Factors Impacting BAX price | BAX will decline at least -0.49% in a week (0% probabilities). TLT(-19%) VIXM(-16%) GDXJ(-9%) BLOK(-7%) UUP(-6%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.49% (StdDev 0.98%) | Hourly BBV | 0 () | Intraday Trend | 0.3% | | | |
|
5 Day Moving Average | $69.83(0.44%) | 10 Day Moving Average | $69.07(1.55%) | 20 Day Moving Average | $68.16(2.9%) | To recent high | -0.1% | To recent low | 10.4% | Market Cap | $35.784b | | | | Baxter International, Inc. provides portfolio of essential renal and hospital products, including acute and chronic dialysis, sterile IV solutions, infusion systems and devices, parenteral nutrition therapies; premixed and oncolytic injectable, bio surgery products and anesthetics, drug reconstitution systems; and pharmacy automation, software and services. It operates through the following segment: Americas, Europe, Middle East & Africa and Asia-Pacific. The company was founded by Davis Baxter in 1931 and is headquartered in Deerfield, IL. |